October 2024
186 articles-

Oct 30 · 23:06Biotechnology Daily
Cue lays off 25%, prioritizing preclinical autoimmune assets over clinical-stage cancer drugs
-

Oct 30 · 23:05Biotechnology Daily
Abbott offers FreeStyle Libre 3 sensor replacements due to inaccurate glucose readings
-

Oct 30 · 23:03Biotechnology Daily
AbbVie axes midstage Alzheimer's program amid 'evolving landscape'
-

Oct 30 · 23:01Biotechnology Daily
Calliditas' liver disease trial hits primary endpoint after clarifications to design
-

Oct 30 · 22:59Bio Business News
Chemomab trumpets liver disease win, but investors retreat
-

Oct 30 · 22:56Bio Business News
In Eisai, Medidata finds its first big buyer for new clinical trial management platform
-

Oct 30 · 22:54Bio Business News
Mirati's Charles Baum takes the helm at Terremoto Biosciences
-

Oct 30 · 22:53Bio Business News
Edwards Lifesciences inks $1.6B in acquisition deals for JenaValve, Endotronix
-

Oct 29 · 22:31Biotechnology Daily
Boston Scientific sees electric 125% EP growth after pulsed field ablation launch
-

Oct 29 · 22:30Biotechnology Daily
Sanofi will drop phase 2 dwarfism drug as part of rare disease clear-out
-

Oct 29 · 22:28Biotechnology Daily
Autobahn Labs partners with Charles River to speed translation of academic research
-

Oct 29 · 22:27Biotechnology Daily
Roche pumps brakes in Pompe disease, axing gene therapy after assessing competition
-

Oct 29 · 22:25Bio Business News
FDA's device center director, Jeff Shuren, to retire
-
Oct 29 · 22:24Bio Business News
Novartis hopes for better luck with bispecifics via $150M upfront Dren Bio deal
-

Oct 29 · 22:23Bio Business News
Viking's obesity med set to charge into phase 3, with $300M earmarked for clinical program
-

Oct 29 · 22:20Bio Business News
Tourette's biotech Asarina to wind down after outreach to 200 companies fails to produce a partner
-

Oct 28 · 23:15Biotechnology Daily
British insurer launches AI-powered clinical trial funding program
-

Oct 28 · 23:13Biotechnology Daily
The brain regions responsible for the placebo effect have been mapped in mice
-

Oct 28 · 23:12Biotechnology Daily
Pfizer’s gene therapy offers alternative to 'burden' of regular infusions, but can it outlast Roctavian?
-

Oct 28 · 23:11Biotechnology Daily
OSE, flying solo after Servier split, suggests symptom improvements for ulcerative colitis prospect
-

Oct 28 · 22:58Bio Business News
Biogen, Sage fail midphase essential tremor trial, extending long wait for new option
-

Oct 28 · 22:57Bio Business News
Insilico Medicine launches AI assistant for drafting medical research papers
-

Oct 28 · 22:55Bio Business News
Cancer-focused Actuate makes 2nd tweak to IPO plans in a week
-

Oct 28 · 22:53Bio Business News
AstraZeneca plants an EGFR tree with Pinetree deal worth $45M